XML 62 R40.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Investments in Unconsolidated Entities (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Equity Method Investments and Joint Ventures [Abstract] |
Investments in Unconsolidated Entities | UScellular's Investments in unconsolidated entities are accounted for using the equity method, measurement alternative method or net asset value practical expedient method as shown in the table below. The carrying value of measurement alternative method investments represents cost minus any impairments plus or minus any observable price changes.
December 31, | 2024 |  | 2023
(Dollars in millions) |  |  |
Equity method investments: |  |  |
Capital contributions, loans, advances and adjustments | $ | 104 |  |  | $ | 104 |
Cumulative share of income | 2,890 |  |  | 2,729 |
Cumulative share of distributions | (2,554) |  |  | (2,385) |
Total equity method investments | 440 |  |  | 448 |
Measurement alternative method investments | 5 |  |  | 4 |
Investments recorded using the net asset value practical expedient | 9 |  |  | 9 |
Total investments in unconsolidated entities | $ | 454 |  |  | $ | 461 |
The following tables, which are based on unaudited information provided in part by third parties, summarize the combined assets, liabilities and equity, and results of operations of UScellular’s equity method investments:
December 31, | 2024 |  | 2023
(Dollars in millions) |  |  |
Assets |  |  |
Current | $ | 1,230 |  |  | $ | 1,003 |
Noncurrent | 6,514 |  |  | 6,383 |
Total assets | $ | 7,744 |  |  | $ | 7,386 |
Liabilities and Equity |  |  |
Current liabilities | $ | 856 |  |  | $ | 762 |
Noncurrent liabilities | 1,628 |  |  | 1,148 |
Partners’ capital and shareholders’ equity | 5,260 |  |  | 5,476 |
Total liabilities and equity | $ | 7,744 |  |  | $ | 7,386 |
Year Ended December 31, | 2024 |  | 2023 |  | 2022
(Dollars in millions) |  |  |  |  |
Results of Operations |  |  |  |  |
Revenues | $ | 7,546 |  |  | $ | 7,277 |  |  | $ | 7,275 |
Operating expenses | 5,926 |  |  | 5,683 |  |  | 5,662 |
Operating income | 1,620 |  |  | 1,594 |  |  | 1,613 |
Other income (expense), net | (3) |  |  | (28) |  |  | (16) |
Net income | $ | 1,617 |  |  | $ | 1,566 |  |  | $ | 1,597 |

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration